Participated in Reprogram Biosciences' seed round alongside Unshackled Ventures and Narya to advance mRNA-based tumor cell reprogramming therapeutics.
Reprogram Biosciences develops innovative immunotherapy using gene reprogramming to turn cancer cells into immune-like cells
Reprogram Biosciences develops innovative immunotherapy using gene reprogramming to turn cancer cells into immune-like cells. The company focuses on groundbreaking cancer treatment methods.